Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03375112
Other study ID # FICB01
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date July 31, 2017
Est. completion date October 1, 2019

Study information

Verified date September 2023
Source Henry Ford Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total hip arthroplasty (THA). This randomized, double-blind, clinical trial will randomize patients to receive either a FICB or placebo after THA. The primary outcomes will be pain scores reported by the patient post-operatively.


Description:

The FICB is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip joint. There have been numerous study assessing it's ability to control pain in the pre and post operative period in patients with hip fractures. However, there is a limited amount of literature on its efficacy after total hip arthroplasty, and no data when a posterior surgical approach to the hip was utilized. Because regional blocks have been shown to decrease pain post operatively after total knee arthroplasty, we hypothesize that the FICB will decrease pain and narcotic use in patients after total hip arthroplasty. This study will aim to recruit 120 patients that will be randomized to receive a FICB or placebo in the recovery room within 30 minutes of leaving the OR. Once the intervention is complete we will collect data on the patients' pain levels, morphine equivalents of narcotic that they used, and how well they worked with physical therapy during their inpatient stay.


Recruitment information / eligibility

Status Completed
Enrollment 122
Est. completion date October 1, 2019
Est. primary completion date October 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients over the age of 18 - Scheduled for total hip arthroplasty at Henry Ford Hospital - Epidural anesthesia during surgery Exclusion Criteria: - Pregnancy - Known intolerance to local anesthetic or narcotics - Revision hip surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Fascia iliaca compartment block
The patient will be brought to the block room within 30 minutes of arriving in recovery. An injection of local anesthetic into the fascia iliaca compartment using ultrasound guidance will be administered. The patient will then be transported back to recovery.
Drug:
Placebo
The patient will be brought to the block room within 30 minutes of arriving in recovery. An ultrasound probe will be placed to the skin and a blunt needle will be touched to the patient's skin in the area that a fascia iliaca compartment block would be performed. The patient will then be transported back to recovery.
Bupivacaine
A one time dose of 40 milliliters of 0.5% bupivacaine will be injected into the fascia iliaca compartment

Locations

Country Name City State
United States Henry Ford Hospital Detroit Michigan

Sponsors (1)

Lead Sponsor Collaborator
Henry Ford Health System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Averaged Pain Score Analog pains scale 0-10. A pain score of 10 represents maximum pain and a pain score of 0 represents no pain. Pain scores were at 30 minute intervals for the first hour post-operative, hourly for the next 4 hours, 2 hour intervals for the next 12 hours, then at 4 hour intervals until the 48 hour post-operative or discharge. The mean of these scores is reported.
Primary Morphine Equivalents Consumed Total morphine equivalents (consumed at 4-hour time intervals) received in postoperative inpatient stay. Postoperative inpatient stay, which averages approximately two days.
Secondary Walking Distance The distance the patient is able to walk with physical therapy during their first session Post operative day one
Secondary Time to Up-and-go Time to up and go test performed on the first postoperative day. This test is administered by having the patient sit in a chair. When the patient is instructed to start, the stand from the chair, walk to a marker ten feet away from the chair, turn around, return to the chair, and sit back down. The time is measured as the time from when the start command is given to when they are returned to a seated position. Post operative day one
Secondary Time to Discharge Readiness Time in hours since surgery to when the patient's pain is controlled on oral medications, has cleared physical and occupational therapy, and has no medical issues that require inpatient treatment. Every 6 hours after surgery until completion of inpatient stay, an average of two days days after surgery
See also
  Status Clinical Trial Phase
Completed NCT05065775 - Bioavailability of Intranasal Dexmedetomidine Phase 4
Completed NCT03540667 - Study of Hip and Knee Arthroplasty in South Africa
Completed NCT04441112 - Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial Phase 2/Phase 3
Active, not recruiting NCT03602105 - Better Before - Better After: Prehabilitation Program for Older Patients Awaiting Total Hip Replacement N/A
Recruiting NCT05366712 - Nexus Evaluation Primary Trident II Uncemented Shell N/A
Not yet recruiting NCT05736016 - Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement N/A
Recruiting NCT05957822 - Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery Phase 4
Not yet recruiting NCT05956769 - Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty N/A
Completed NCT03069183 - Ultrasound-guided Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Total Hip Arthroplasty Phase 2/Phase 3
Enrolling by invitation NCT04928924 - Immediate Post-THA Functional Assessment